Launching a therapy has become increasingly challenging, with only 34% of launches meeting their year-one goals (Evaluate Pharma, McKinsey). In addition, launches have also become more complex, with additional stakeholders to consider as well as the careful navigation of siloed, enterprise-wide functions and dynamic, fragmented data solutions. Not surprisingly, the path to a successful launch can be very narrow.
If Data is the new oil, then you are dealing with Crude. Precision has the refinery to generate the enriched, high-octane gasoline you need to power your commercial decision engines.
Over the past few years, pharmaceutical manufacturers have launched an increasing number of products covered under a health plan’s medical benefit. In response, health plans are exploring applying tools used successfully on the pharmacy benefit to the medical benefit.
Precision Master Data Management (MDM) software enables the critical steps of the mastering process to facilitate downstream analytics across the Drug, HCP, and Healthcare Organization (HCO) domains. This paper addresses some of the key challenges and highlights best practices for connecting datasets and creating a single source of truth in each respective domain.
As large pharmacy benefit managers (PBMs) create group purchasing organizations (GPOs) to manage the regulatory risk and transition to administrative fees as a source of revenue rather than manufacturer rebates, there is a lot of mystery surrounding the operation of these new entities.
With the explosion of contract network pharmacies in the last few years, we thought the tale of the 340B gold rush was on its last page. Then came along the health system-owned specialty pharmacies to add some more pages for us to read and understand the implications for manufacturers.
Miss any of our recent Precision Value & Health events? Check out our monthly marketing activities calendar to catch up on-demand, and stay ahead of upcoming dates!
PRECISION OFFERS LIFE SCIENCE CLIENTS DEEPER CONNECTIONS TO HCPs THROUGH LAUNCH OF ADVANCED...
Bethesda, Maryland and San Francisco, California—February 2, 2021—PRECISIONxtract and Datavant announced a market-shifting partnership...
Just collecting data is not enough, especially if companies want to make use of artificial intelligence (AI) or other advances in data analytics to...
The Precision Value & Health family of brands is now Precision AQ
Precision AQ helps life sciences companies navigate the complexities of commercialization across a product’s lifecycle. Our team is comprised of experts, advisors, and creators working to ensure patients have access to life-changing medicines.
Our global offerings include:
Our name, which stands for Precision Access Quotient, reflects our approach to removing barriers – fusing together science (IQ, or Intelligence Quotient) and empathy (EQ, or Emotional Quotient). The result is “AQ: Access Quotient”, a critical ingredient in navigating the therapy-to-patient journey informed by data-driven analytics and insights.
To find out more about our global services and our unified mission, empowering access to life-changing medicines for all, visit: Precision AQ
